Purpose
To support and advance the development of novel oral long-acting agents that are safe, efficacious, well tolerated, easy to take, and cost effective to simplify HIV treatment and improve adherence to antiretroviral therapy in LMICs.
Grantee
Division
Global Health
Date
SEPTEMBER 2026
Region served
GLOBAL
Committed amount
$7,142,697
Grant topic
HIV
Duration (months)
19
Grantee location
Rahway, New Jersey, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.